Search Results

Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout

Authors: Navarra, Sandra; Rubin, Bernard R.; Yu, Qinfen; Smugar, Steven S.; Tershakovec, Andrew M.

Source: Current Medical Research and Opinion, Volume 23, Number 7, July 2007 , pp. 1685-1691(7)

Publisher: Informa Healthcare

Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies

Authors: Smugar, Steven S.; Schnitzer, Thomas J.; Weaver, Arthur L.; Rubin, Bernard R.; Polis, Adam B.; Tershakovec, Andrew M.

Source: Current Medical Research and Opinion, Volume 22, Number 7, July 2006 , pp. 1353-1367(15)

Publisher: Informa Healthcare

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies

Authors: Birbara, C.; Ruoff, G.; Sheldon, E.; Valenzuela, C.; Rodgers, A.; Petruschke, R.A.; Chang, D.J.; Tershakovec, A.M.

Source: Current Medical Research and Opinion, Volume 22, Number 1, January 2006 , pp. 199-210(12)

Publisher: Informa Healthcare

Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study

Authors: Zerbini, C.; Ozturk, Z.E.; Grifka, J.; Maini, M.; Nilganuwong, S.; Morales, R.; Hupli, M.; Shivaprakash, M.; Giezek, H.; The Etoricoxib CLBP Study Group,

Source: Current Medical Research and Opinion, Volume 21, Number 12, December 2005 , pp. 2037-2049(13)

Publisher: Informa Healthcare

Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial

Authors: Chang, David J.; Desjardins, Paul J.; Bird, Steven R.; Black, Peter; Chen, Erluo; Petruschke, Richard A.; Geba, Gregory P.

Source: Current Medical Research and Opinion, Volume 20, Number 6, 1 June 2004 , pp. 939-949(11)

Publisher: Informa Healthcare

Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial

Authors: Kivitz, Alan J.; Greenwald, Maria W.; Cohen, Stanley B.; Polis, Adam B.; Najarian, Daryl K.; Dixon, Mary E.; Moidel, Robert A.; Green, Jerry A.; Baraf, Herbert S. B.; Petruschke, Richard A.; Matsumoto, Alan K.; Geba, Gregory P.

Source: Journal of the American Geriatrics Society, Volume 52, Number 5, May 2004 , pp. 666-674(9)

Publisher: Blackwell Publishing

A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis

Authors: Zacher J.; Feldman D.; Gerli R.; Scott D.; Hou S.-M.; Uebelhart D.; Rodger I.W.; Ozturk Z.E.

Source: Current Medical Research and Opinion, Volume 19, Number 8, 1 December 2003 , pp. 725-736(12)

Publisher: Informa Healthcare

(214) Rofecoxib Provides Superior Relief of Pain in Osteoarthritis (OA) Compared to Celecoxib

Authors: Kivitz, A.J.; Schnitzer, T J.; Greenwald, M.; in Medicine, Advances; Matzura-Wolfe, D.; Polis, A.B.; Dixon, M.E.; Dobbins, T.W.; Geba, G.P.

Source: Pain Medicine, Volume 2, Number 3, September 2001 , pp. 244-244(1)

Publisher: Blackwell Publishing

Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial

Authors: Chang D.J.; Fricke J.R.; Bird S.R.; Bohidar N.R.; Dobbins T.W.; Geba G.P.

Source: Clinical Therapeutics, Volume 23, Number 9, September 2001 , pp. 1446-1455(10)

Publisher: Elsevier